---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-036020"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2022-12-20T23:59:59+00:00"
generated_at: "2026-06-21T01:29:25.355438+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Oragenics receives NYSE American deficiency notice for low stock price; must cure by June 19, 2023

## Summary
- NYSE American notified OGEN that its 30-day average stock price fell below $0.20, violating Section 1003(f)(v).
- Stock will trade with 'BC' designation indicating non-compliance; delisting not immediate.
- Company has until June 19, 2023 to demonstrate sustained price improvement or effect a reverse stock split.
- If not cured by deadline, NYSE American may commence delisting proceedings, threatening liquidity and listing status.
- Company intends to monitor price and consider options; no impact on business operations or SEC reporting requirements.

## SEC filing metadata
- accession: 0001493152-22-036020
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2022-12-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315222036020/0001493152-22-036020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315222036020/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-036020
- JSON: https://secwatch.observer/filing/0001493152-22-036020.json
- Plain text: https://secwatch.observer/filing/0001493152-22-036020.txt

## Key facts
- Listing & Compliance Notices
  ORAGENICS INC received a nyse_american noncompliance notice notice regarding other (rules 1003(f)(v), 1009).
  - Exchange: nyse american
  - Notice: noncompliance notice
  - Rules: 1003(f)(v), 1009
  source text: December 19, 2022, Oragenics, Inc. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (“Section 1003(f)(v)”) because its shares of common stock have been selling for a substantial period of time at a low price per share, which NYSE American determined to be a 30-trading-day average price of less than $0.20 per share. The Notice has no immediate effect on the listing or trading
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315222036020/0001493152-22-036020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.